Effect of low doses of L-NAME on methamphetamine-induced dopaminergic depletion in the rat striatum T. AbekawaT. OhmoriT. Koyama Pages: 1219 - 1230
Opioid peptides alleviated while naloxone potentiated methamphetamine-induced striatal dopamine depletion in mice L. YuY.-M. KuoC.-F. G. Cherng Pages: 1231 - 1237
The effect of low oral doses of (−)-deprenyl and its metabolites on DSP-4 toxicity D. HaberleÉ. SzököK. Magyar Pages: 1239 - 1247
Functional regional distribution of histamine receptors in the rat hippocampus: modulation of learning of an active avoidance response E. O. AlvarezA. M. Banzan Pages: 1249 - 1261
Neurochemical findings in the MPTP model of Parkinson's disease N. SchmidtB. Ferger Pages: 1263 - 1282
Clinical characteristics of neuroleptic-induced parkinsonism S. Hassin-BaerP. SirotaN. Giladi Pages: 1299 - 1308
High-dose therapy with ropinirole in patients with Parkinson's disease M. MüngersdorfU. SommerH. Reichmann Pages: 1309 - 1317
The beneficial effect of cholinesterase inhibitors on patients suffering from Parkinson's disease and dementia E. A. WerberJ. M. Rabey Pages: 1319 - 1325
Cognitive relapse after discontinuation of drug therapy in Alzheimer's disease: cholinesterase inhibitors versus nootropics M. RainerH. A. M. MuckeK. A. Jellinger Pages: 1327 - 1333
A study of cranial computertomograms in very early and early onset schizophrenia F. BaduraG.-E. TrottA. Warnke Pages: 1335 - 1344